Swiss Helmet Tech Targets Alzheimer's, Depression

Neurodegenerative diseases like dementia, depression, and Alzheimer's are increasingly impacting India's aging population. With nine million people currently affected by dementia alone, this number is projected to rise significantly, placing a growing strain on families and healthcare systems.

In response, Swiss startup Bottneuro is developing MiaMind, a personalized helmet that uses transcranial electrical stimulation. This device, custom-fitted using MRI scans, delivers targeted electrical currents to the brain to potentially enhance cognitive functions or regulate mood.

The MiaMind system is designed for at-home use, allowing patients to conduct therapy sessions conveniently. While clinical trials are ongoing to confirm its efficacy for conditions like Alzheimer's, the technology has demonstrated safety in initial testing.

This non-invasive approach represents a potential advancement in managing chronic brain disorders. As India grapples with a rising burden of these conditions, innovative therapies like MiaMind offer a glimmer of hope for improved patient care.